RET and familial pancreatic carcinoma: This finding was supported by a later study in which enhanced RET overexpression promotes pancreas tumorigenesis and perineural invasion using a transgenic mouse model of pancreatic cancer (197), suggesting that enhanced activity of wild-type RET is adequate to promote metastatic pancreatic cancer progression.